Journal article icon

Journal article

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

Abstract:

BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are administered 2 months apart for children aged 12–23 months, with a booster dose 12–24 months later. Our objective was to provide data on persistence of human serum bactericidal antibody (hSBA) titres in children up to 4 years of age after initial doses at 12–24 months, and immunogenicity of a booster dose at 48 months of age compared with vaccine-naive children. METHODS: Children previously imm...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1503/cmaj.161288

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Paediatrics
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Paediatrics
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Paediatrics
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Expand authors...
Novartis Vaccines Division More from this funder
Publisher:
Canadian Medical Association Publisher's website
Journal:
CMAJ Journal website
Volume:
189
Issue:
41
Pages:
E1276-E1285
Publication date:
2017-10-15
Acceptance date:
2017-06-12
DOI:
EISSN:
1488-2329
ISSN:
0820-3946
Pubs id:
pubs:736967
URN:
uri:b767f3a0-072f-49c7-9dfa-bc85e30f05c5
UUID:
uuid:b767f3a0-072f-49c7-9dfa-bc85e30f05c5
Local pid:
pubs:736967

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP